Inventor
BACHAR-LUSTIG ESTHER
IL13 patents
⚠️ This page may combine multiple inventors who share the name “BACHAR-LUSTIG ESTHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YEDA RES & DEV
11 patentsUS10369172B2Aug 6, 2019
Combination therapy for a stable and long term engraftment
YEDA RES & DEV12 citations92
US10434121B2Oct 8, 2019
Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion
YEDA RES & DEV6 citations83
US10961504B2Mar 30, 2021
Veto cells generated from memory T cells
YEDA RES & DEV6 citations81
US12391916B2Aug 19, 2025
Veto cells generated from memory T cells
YEDA RES & DEV1 citations72
US11773372B2Oct 3, 2023
Veto cells generated from memory T cells
YEDA RES & DEV1 citations70
US11555178B2Jan 17, 2023
Genetically modified veto cells and use of same in immunotherapy
YEDA RES & DEV2 citations69
US10751368B2Aug 25, 2020
Methods of transplantation and disease treatment
YEDA RES & DEV6 citations69
US11504399B2Nov 22, 2022
Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion
YEDA RES & DEV0 citations62
US11497776B2Nov 15, 2022
Combination therapy for a stable and long term engraftment
YEDA RES & DEV0 citations62
US12133866B2Nov 5, 2024
Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
YEDA RES & DEV0 citations60
US11324777B2May 10, 2022
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
YEDA RES & DEV1 citations60
REISNER YAIR
2 patentsUS9738872B2Aug 22, 2017
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
REISNER YAIR12 citations82
US9421228B2Aug 23, 2016
Use of anti third party central memory T cells for anti-leukemia/lymphoma treatment
REISNER YAIR12 citations80